Apollomics (APLM) Preferred Stock Liabilities (2020 - 2022)
Apollomics' Preferred Stock Liabilities came in at $511.86 million for Q4 2022, up 58.9% from $322.22 million a year earlier.
Analysis
Apollomics (APLM) Preferred Stock Liabilities (2020 - 2022) Analysis & Trends
- Going back by year, Preferred Stock Liabilities was $322.22 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Apollomics | 48.93 Mn | 7.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 511.86 Mn |
| Dec 31, 2021 | 322.22 Mn |
| Dec 31, 2020 | 322.22 Mn |
API Access
Apollomics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=APLM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "APLM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=APLM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();